Carisma Therapeutics Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Steve Kelly
Chief executive officer
US$3.5m
Total compensation
| CEO salary percentage | 13.2% |
| CEO tenure | 1.7yrs |
| CEO ownership | n/a |
| Management average tenure | 1.5yrs |
| Board average tenure | 1.7yrs |
Recent management updates
Recent updates
Companies Like Carisma Therapeutics (NASDAQ:CARM) Could Be Quite Risky
Sep 02
US$8.40: That's What Analysts Think Carisma Therapeutics, Inc. (NASDAQ:CARM) Is Worth After Its Latest Results
May 12Investors Don't See Light At End Of Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Tunnel And Push Stock Down 26%
Apr 19We're A Little Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Rate
Mar 26Lacklustre Performance Is Driving Carisma Therapeutics, Inc.'s (NASDAQ:CARM) 26% Price Drop
Jan 21The Market Doesn't Like What It Sees From Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Revenues Yet As Shares Tumble 27%
Dec 07Analyst Forecasts Just Became More Bearish On Carisma Therapeutics, Inc. (NASDAQ:CARM)
Nov 12Here's Why We're Watching Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation
Oct 05We're Hopeful That Carisma Therapeutics (NASDAQ:CARM) Will Use Its Cash Wisely
Jun 15CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$64m |
| Jun 30 2024 | n/a | n/a | -US$73m |
| Mar 31 2024 | n/a | n/a | -US$81m |
| Dec 31 2023 | US$4m | US$461k | -US$87m |
| Sep 30 2023 | n/a | n/a | -US$83m |
| Jun 30 2023 | n/a | n/a | -US$80m |
| Mar 31 2023 | n/a | n/a | -US$75m |
| Dec 31 2022 | US$666k | US$440k | -US$61m |
| Sep 30 2022 | n/a | n/a | -US$57m |
| Jun 30 2022 | n/a | n/a | -US$49m |
| Mar 31 2022 | n/a | n/a | -US$43m |
| Dec 31 2021 | US$1m | US$416k | -US$41m |
Compensation vs Market: Steve's total compensation ($USD3.50M) is above average for companies of similar size in the US market ($USD647.72K).
Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.
CEO
Steve Kelly (59 yo)
1.7yrs
Tenure
US$3,504,425
Compensation
Mr. Steven Kelly, also known as Steve, is President, Chief Executive Officer and Director of Carisma Therapeutics, Inc. He served as President, Chief Executive Officer and Director of CARISMA Therapeutics...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.7yrs | US$3.50m | no data | |
| Co-Founder & Chief Scientific Officer | 1.7yrs | US$1.60m | 1.16% $ 411.7k | |
| CFO, Chief Compliance Officer | 1.7yrs | US$1.66m | 0% $ 0 | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| General Counsel & Corporate Secretary | 1.4yrs | no data | no data | |
| Senior Vice President of Human Resources | 1.4yrs | no data | no data | |
| Chief Business Officer | 4.8yrs | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| Senior Vice President of Technical Operations | less than a year | no data | no data |
1.5yrs
Average Tenure
52.5yo
Average Age
Experienced Management: CARM's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.7yrs | US$3.50m | no data | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Independent Chairman of the Board | 1.7yrs | US$271.55k | 0.00099% $ 351.3 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Independent Director | 1.7yrs | US$220.20k | 0.029% $ 10.3k | |
| Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.8yrs | no data | no data |
1.7yrs
Average Tenure
64yo
Average Age
Experienced Board: CARM's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.